Figure 1From: Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis Meta-analysis examining preoperative radiotherapy and surgery compared to surgery alone: mortality at one year. Overall risk ratio = 1.01 (95% CI, 0.88 to 1.16; p = 0.87)Back to article page